The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

AACR: 21st Century Cures a “Model for An Open and Honest Conversation”

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Almost one year ago (on April 30, 2014), House Energy and Commerce Committee Chairman Fred Upton (R-Mich.), along with Oversight and Investigations Subcommittee Ranking Member Diana DeGette (D-Colo.) announced the launch of 21st Century Cures, an initiative aimed at accelerating the pace of cures and medical breakthroughs in the United States by ensuring that our laws are keeping pace with innovation.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
José Baselga
President, American Association for Cancer Research; Physician-in-chief, chief medical officer, Memorial Sloan Kettering Cancer Center
William S. Dalton
Chair, AACR Science Policy & Government Affairs Committee; chief executive officer, M2Gen; Director, DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

ACS report: Cancer mortality continues to drop despite rising incidence in women

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
By Yiqing Wang
Guest Editorial

Cedars-Sinai Cancer’s model of care ensured patient care amid wildfires

Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 
By Dan Theodorescu, Robert A. Figlin, Howard M. Sandler and Joan August
Byline
José Baselga
President, American Association for Cancer Research; Physician-in-chief, chief medical officer, Memorial Sloan Kettering Cancer Center
William S. Dalton
Chair, AACR Science Policy & Government Affairs Committee; chief executive officer, M2Gen; Director, DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account